ABOUT BUTTON

Button Tech is a community of people who are committed to life sciences, medical, and healthcare technology through searching and helping right people and right team.

Our mission is to help life science, medical, and healthcare entrepreneurs and companies find more high-quality partnering opportunities and learn more necessary knowledge when they plan to explore global markets, especially Asian markets, and address fundamental challenges in globalization.

WHAT WE DO

Button Tech is focused on helping innovative life sciences, medical, and healthcare companies grow and penetrate global markets.

Our proprietary platform uses computer algorithm technology to help entrepreneurs and companies analyze global market trends and find potential global partnering opportunities.

Our backend advisory service team provides cross-border financial advisory services, market research, and strategic technology advice. We also provide software development services for US healthcare IT companies as a quick landing of the ideas.

CLIENTS
Pharmaceutical
Biotech
MedTech
Digital Healthcare
  • Sinorda is a biotech company from Sweden focusing on the project portfolio in clinical phases with fast development time and low risk. The ongoing pipelines include SND001 in Phase II (GI field), SND002 entering Phase II and SND 005 in Phase II (both are in Immuno-Oncology field). http://www.sinorda.com
    Symic Bio is a biotech company based in Silicon Valley who develops an innovative platform called Holozyme. Halozyme’s primary technology is based on its proprietary recombinant human hyaluronidase enzyme (rHuPH20) that degrades hyaluronan, or HA. HA is a glycosaminoglycan, a chain of natural sugars that is a component of normal tissue, such as skin and cartilage and can also accumulate around many solid cancerous tumors. The ongoing pipelines include SB030 in Phase II (PVD indication) and SB061 entering Phase IIb (OA indication). http://www.symic.bio
  • FlowPharma uses computational modeling and AI deep learning to design synthetic, CTL Immuno-Oncology therapeutics. The company's lead product is FlowVax HPV​ to Treat Cervical Cancer. The company is led by a group of veterans and serial entrepreneurs in the Biotech field and these entrepreneurs have brought 3 companies to IPO in the past 30 years. https://www.flowpharma.com
    Founded in 2011, DiaCarta is a leading translational genomics and personalized diagnostics company based in Richmond, California. It provides ultra-sensitive detection tools for cancer diagnosis, therapy identification and prognosis monitoring. Their mission is to provide ultra-sensitive and advanced technologies that will redefine the way molecular diagnostics and translational genomics impact healthcare treatment plans and the well-being of individuals around the world. https://diacarta.com
    Berry Genomics was founded in May 2010 and became the first genomic company to be listed on the main board of China. Berry Genomics is specializing in developing and commercializing technologies for life sciences and clinical applications. Among the clinical applications, the company is dedicated to developing next generation sequencing (NGS) based tests for genetic disease and cancer from preconception to adulthood. http://www.berrygenomics.com/enberry
  • Advanced Resin Therapeutics develops a novel, resin-based, drug delivery system that promotes topical and transmucosal delivery of medications more efficiently and effectively than current technologies. The company has grown its IP portfolio to include 11 issued patents worldwide and 17 pending patents. The company's lead product opportunity is NicoSwab, a fast-acting, long-lasting nicotine replacement product. https://advancedresin.com
    LakeBio focuses on the molecular diagnosis. It develops an innovative molecular diagnosis system that provides clients one-stop services. Its leading products consist of proprietary cell-free DNA collection tubes (a cost-saving substitute of Streck) to store blood samples in room temperature, fast DNA extraction kits, and digital PCR equipments.
    12 SIGMA Technologies was founded in April 2015 in San Diego, California. They are one of the first companies to introduce deep learning into modern medical image diagnosis and medical data analysis. They work closely with partners in applied medical diagnostics, technical research and clinical trials. http://www.12sigma.cn
  • Versl leverages its proprietary technology and massive doctor networking to champion the service of eye screening for new born babies in China. Its technology allows high definition, wide field, colour images to be captured of the backs of infants eyes which can be uploaded to a proprietary cloud platform and viewed by Ophthalmologists for immediate diagnosis.
WHO WE WORK WITH
Address: Our office is located at Silicon Valley, California2665 Marine Way, Mountain View, CA